See also this year's filing and all EDGAR filings for this company.
PDF Report 0001023024_2025_ANI_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001023024, ANI Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 527,684,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 601,824,000 |
| 2 | PropertyPlantAndEquipmentNet | 56,863,000 |
| 3 | remainder_Assets | 97,326,000 |
| 4 | LiabilitiesCurrent | 193,680,000 |
| 5 | LiabilitiesNoncurrent | 314,889,000 |
| 6 | remainder_Liabilities | 346,598,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 689,103,851 |
| 9 | ResearchAndDevelopmentExpense | 43,154,555 |
| 10 | remainder_Expenses | 478,095,671 |
| 11 | remainder_Revenues | 1,216,322,642 |
| 12 | remainder_NetIncome | -22,220,963 |
| 13 | remainder_ComprehensiveNetIncome | -3,500,554 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,283,697,000 |
| 1 | Liabilities | 855,167,000 |
| 2 | Expenses | 1,210,354,077 |
| 3 | Revenues | 1,216,322,642 |
| 4 | StockholdersEquity | 428,530,000 |
| 5 | NetIncome | -16,252,398 |
| 6 | ComprehensiveNetIncome | -18,002,675 |
| 7 | BaseVar | 2,295,631,118 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.857 |
| 9 | EconomicCapitalRatio | 2.19 |
Edgar->Model Mapping
Feature Distribution
Change over Time
